Pancreatitis with didanosine and tenofovir disoproxil fumarate [corrected].
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12942419.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Pancreatitis occurs in up to 7% of patients infected with human immunodeficiency virus who are treated with standard doses of didanosine. Tenofovir disoproxil fumarate increases the plasma levels of didanosine and, thus, the combination of these agents may increase the risk of pancreatitis. Four cases of pancreatitis that occurred during administration of this drug combination are examined, including 1 that resulted in death.
Medical subject headings
- Adenine
- Didanosine
- Organophosphonates
- Organophosphorus Compounds
- Pancreatitis